Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic ...

By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized vaccine continued to cut the risk of death or recurrence of the most deadly ...

Five years ago, a group of high-risk skin cancer patients received a bespoke vaccine. The data is finally in, and the results ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.

A combination of intismeran autogene and Keytruda significantly prolonged recurrence-free survival in melanoma.

Vaccines that protect against infectious diseases like the flu or pneumonia are commonly made from a weakened form of the virus. It is injected into the body and causes an immune response that helps ...

Long-term follow-up data from a phase 2b trial of Moderna and MSD's mRNA-based vaccine against melanoma, intismeran autogene (mRNA-4157), show an impressive 49% reduction in the risk of disease ...

As cervical cancer awareness month concludes, health officials stress the importance of regular screenings and the HPV ...

Maybe in Norway but probably not in the U.S., expert says ...

Even after surgery and chemotherapy, some cancers, like pancreatic and colorectal, maintain a foothold in the body and ...